H
Harlan M. Krumholz
Researcher at Yale University
Publications - 1966
Citations - 177853
Harlan M. Krumholz is an academic researcher from Yale University. The author has contributed to research in topics: Myocardial infarction & Population. The author has an hindex of 85, co-authored 1826 publications receiving 159216 citations. Previous affiliations of Harlan M. Krumholz include Veterans Health Administration & Robert Wood Johnson Foundation.
Papers
More filters
Journal ArticleDOI
National and Regional Trends in Heart Failure Hospitalization and Mortality Rates for Medicare Beneficiaries, 1998-2008
TL;DR: In this article, changes in patient demographics and comorbidities, heart failure hospitalization rates, and 1-year mortality rates were examined in the United States, nationally and by state or territory.
Journal ArticleDOI
Increasing value and reducing waste: addressing inaccessible research.
An-Wen Chan,Fujian Song,Andrew J. Vickers,Tom Jefferson,Kay Dickersin,Peter C Gøtzsche,Harlan M. Krumholz,Harlan M. Krumholz,Davina Ghersi,H. Bart van der Worp +9 more
TL;DR: Three main actions are warranted: academic institutions and funders should reward investigators who fully disseminate their research protocols, reports, and participant-level datasets, and standards for the content of protocols and full study reports should be rigorously developed and adopted for all types of health research.
Journal ArticleDOI
American College of Cardiology key data elements and definitions for measuring the clinical management and outcomes of patients with acute coronary syndromes. A report of the American College of Cardiology Task Force on Clinical Data Standards (Acute Coronary Syndromes Writing Committee).
Christopher P. Cannon,Alexander Battler,Ralph G. Brindis,Jafna L. Cox,Stephen G. Ellis,Nathan R. Every,John T. Flaherty,Robert A. Harrington,Harlan M. Krumholz,Maarten L. Simoons,Frans Van de Werf,William S. Weintraub,Kristi Mitchell,Susan L Morrisson,H. Vernon Anderson,David S. Cannom,W. Randolph Chitwood,Joaquin E. Cigarroa,Ruth L. Collins-Nakai,Raymond J. Gibbons,Frederick L. Grover,Paul A. Heidenreich,Bijoy K. Khandheria,Suzanne B. Knoebel,Harlan L Krumholz,David J. Malenka,Daniel B. Mark,Charles R. McKay,Eugene R. Passamani,Martha J. Radford,Ronald N Riner,Janice B. Schwartz,Richard E. Shaw,Richard J. Shemin,Douglas B. Van Fossen,Edward D. Verrier,Matthew W. Watkins,Dawn R. Phoubandith,Tori Furnelli +38 more
Journal ArticleDOI
Association of Serum Digoxin Concentration and Outcomes in Patients With Heart Failure
TL;DR: It is demonstrated that higher SDCs were associated with increased mortality and suggested that the effectiveness of digoxin therapy in men with heart failure and a left ventricular ejection fraction of 45% or less may be optimized in the SDC range of 0.5 to 0.8 ng/mL.
Journal ArticleDOI
Admission glucose and mortality in elderly patients hospitalized with acute myocardial infarction: implications for patients with and without recognized diabetes.
Mikhail Kosiborod,Saif S. Rathore,Silvio E. Inzucchi,Frederick A. Masoudi,Yongfei Wang,Edward P. Havranek,Harlan M. Krumholz +6 more
TL;DR: Elevated glucose is common, rarely treated, and associated with increased mortality risk in elderly acute myocardial infarction patients, particularly those without recognized diabetes.